
Consortium International Holdings, LLC is a well-established US based medical device entity that has served the US domestic and international markets since 2017. Our market interests continue to expand and now offers an impressive line of rapid diagnostic test devices for the detection of multiple infectious diseases including the SARS-CoV-2 virus, HCV, HPV and other infectious disease including HIV as well as multiple Vector Diseases including Dengue, Malaria, Zika and others.
We are now introducing our Yellow Fever (NS-1Ag and Ab) which delivers high sensitivity and specificity. Our H5 Bird flu RDT is unique in the world markets as it specifically identifies the presence of H5 in human and animals. Also included in our product line is our Real-Time Molecular (PCR) and Readers. Reagents are offered under both temperature-controlled state or lyophilized.
The most recent addition to the Consortium line of products is our PREVENTOGEN wound care products which deliver exceptional performance for both surgical and post-surgical applications as well as for diabetic foot and pressure ulcers.
With the expanding transmission of H5N1 from animal to human infection, our H5 Specific Rapid Diagnostic leads the way in a most accurate H5 detection, ruling out other Influenza A infections.
In additional to the line of diagnostics that we offer, Consortium International also offers a complete line of PCR Readers including the innovative, portable MA-1630Q Series Portable Real-Time Fluorescence Quantitative PCR Reader as well as the newly introduced MQ-4164 and the laboratory based Real Time Quantitative Thermal Cycler Reader. Also available to our international markets only outside of the USA, is the Diagnostic Virus Sample Tube with Swab for either nasopharyngeal or oropharyngeal sampling.
Our mission is to provide a complete system of high quality and reliable devices that meet the market needs and which targets both professional providers and the public health markets where authorized for such distribution. All products are produced under the highest quality standards delivering to our clients around the world, diagnostics that are reliable and can deliver repeatable test results.
Note: Only those products that have the US FDA Emergency Use Authorization (EUA) or which carry the US FDA 510K are available for distribution within the United States.
All products offered by Consortium International Holdings carry ISO as well as other quality certificates issued by the appropriate government entities.
Consortium International will assist in providing all appropriate and necessary documentation required for the registration of the product into the Country of Destination.
Contact us at:
Consortium International Holdings, LLC
Fort Lauderdale, Florida 33308USA
E-mail: info@consortiummiami.com
Direct & WhatsApp +1.305.978.4590
